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Low bone mass and osteoporosis in women referring themselves
to dual X-ray absorptiometry - experience with a health
promotion action
Abstract
Aims: This retrospective analysis was done to describe the difference in the prevalence of
osteoporosis/low bone mass between women referring themselves to bone mineral density (BMD)
testing with dual X-ray absorptiometry (DXA) and women referred by their family practitioner.
Methods: Women were recruited by a health promotion action in a Swiss weekly periodical and
compared with female patients sent by their physician for DXA testing for various medical indications
during the same period. Patients under steroid treatment, known previous fracture and undergoing
follow-up for low bone mass were excluded. Self referred women were compared to female patients
aged 40 years and older and the same evaluation was repeated for women aged 65 and older.
Results: No differences were found in the prevalence of osteoporosis /low bone mass in women referred
by their physician vs those who were self referred. However, a significant difference was found with
age: the self referred women were 63.1 ± 8.6 years of age whereas the patient group's mean age was
59.7 ± 9.4 (p=0.0001, 95% CI of the difference: 21 - 61 years).
Conclusion: We suggest that health promotion actions might be able to recruit the correct candidates for
BMD testing, since we found no significant difference in the prevalence of osteoporosis/ low bone mass
between self referred and physician referred women. Our data further suggest that physicians may react
earlier on their patient's risk profiles than the time frame of action by the self-referred women.
 The Open Epidemiology Journal, 2010, 3, 29-33 29 
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Abstract: Aims: This retrospective analysis was done to describe the difference in the prevalence of osteoporosis/low 
bone mass between women referring themselves to bone mineral density (BMD) testing with dual X-ray absorptiometry 
(DXA) and women referred by their family practitioner. 
Methods: Women were recruited by a health promotion action in a Swiss weekly periodical and compared with female 
patients sent by their physician for DXA testing for various medical indications during the same period. Patients under 
steroid treatment, known previous fracture and undergoing follow-up for low bone mass were excluded. Self referred 
women were compared to female patients aged 40 years and older and the same evaluation was repeated for women aged 
65 and older. 
Results: No differences were found in the prevalence of osteoporosis /low bone mass in women referred by their physician 
vs those who were self referred. However, a significant difference was found with age: the self referred women were 63.1 
± 8.6 years of age whereas the patient group’s mean age was 59.7 ± 9.4 (p=0.0001, 95% CI of the difference: 21 – 61 
years). 
Conclusion: We suggest that health promotion actions might be able to recruit the correct candidates for BMD testing, 
since we found no significant difference in the prevalence of osteoporosis/ low bone mass between self referred and 
physician referred women. Our data further suggest that physicians may react earlier on their patient’s risk profiles than 
the time frame of action by the self-referred women. 
Keywords: Osteoporosis, health promotion, dual X-ray absorptiometry. 
INTRODUCTION 
 Osteoporosis is a growing health care problem in 
societies with aging populations. Therefore, information of 
elderly persons to increase awareness of osteoporosis is 
important. Previous works show that health promotion 
programs can help to reach populations at risk for 
osteoporotic fractures, thus, reducing morbidity and 
mortality [1-3]. Information about osteoporosis and 
increased fracture risk both for populations as well as 
individual patients and their treating practitioners is an 
important part of prevention programs [4, 5]. 
 It has been suggested that screening examination of bone 
mineral density (BMD) using dual energy X-ray 
absorptiometry (DXA) may improve awareness and impact 
on initiation of treatment and prevention of osteoporosis [1]. 
DXA is the standard method for BMD measurements used 
for the diagnosis of osteoporosis and assessment of fracture 
risk [6-9]. According to the official positions of the 
International Society for Clinical Densitometry (ISCD), 
BMD testing should be considered in women 65 years of age  
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and older, in postmenopausal women under the age of 65 
with risk factors and in men 70 years of age and older [9]. 
Additionally, patients with diseases or conditions associated 
with a low bone mass or bone loss and patients taking 
medication associated with these findings should undergo 
BMD testing [9]. However, DXA is usually not widely used 
in screening programs because of its limited availability and 
relatively high costs. 
 The aim of this retrospective study was to describe 
prevalence of osteopenia and osteoporosis in women who 
referred themselves to BMD testing with DXA as part of a 
health promotion program. They were compared to female 
patients who were sent by a family physician. Both the 
limitations of this health promotion action and the 
differences between the two groups will be discussed. 
MATERIALS AND METHODOLOGY 
Self-Referring Women and Patients 
 In 2003 a promotion was launched in a large Swiss 
weekly periodical entitled ‘big osteoporosis action’ (Grosse 
Osteoporose-Aktion der Schweizer Illustrierten). The 
Schweizer Illustrierte is one of the largest Swiss weekly 
periodicals in German language with an edition of 
approximately 250’000 prints at that time. A voucher was 
included for the readers of this magazine enabling them to  
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have their BMD measured by a standard DXA in one of 19 
centres in the German speaking part of Switzerland at a 
reduced fee (175.00 Swiss Francs). The centres included 
large district hospitals, specialized orthopaedic/ 
rheumatology clinics and the three University Hospital 
centres. Only centres with staff experienced in DXA 
participated in this promotion. 
 In the advertisement, a statement was given that BMD 
measurement should be done regularly in women aged 65 
and above. There were no further restrictions indicated on 
the voucher regarding risk factors of persons who should 
preferably undergo DXA scanning for the assessment of 
fracture risk. The promotion was advertised during 4 weeks 
and the population was free to use the voucher during a 4 
months period from September to December 2003). The 
persons participating in this promotion received the result of 
their DXA test directly with a hard copy of the measurement 
results and a diagnosis of normal bone density, osteopenia or 
osteoporosis. This procedure allowed them to discuss the 
result to their family physician/ specialist. Furthermore, the 
voucher included the offer to further discuss the results of 
the DXA scan with the physician responsible for the 
measurement. The persons participating in this promotion 
had to pay their fee directly to the institution and they could 
not have the DXA and consultation paid by their health 
insurance. 
 All the women who took part in this promotion and had 
DXA scanning at the Osteoporosis Center of the University 
Hospital of Zurich were included in this evaluation. 
 Patients sent by their family practitioner with various 
indications for DXA scanning during the same period served 
as the reference population for comparison with the 
population recruited by the health promotion action. 
 The data were retrospectively evaluated after the end of 
the promotion period. The evaluation was done in 
accordance with the ethical guidelines of our institutional 
review board and the use of data for this retrospective 
analysis was approved by our local ethics committee. 
DXA Measurements 
 In our institution, the DXA measurements were 
performed on the supine patient at the lumbar spine (L2-L4) 
and the non-dominant hip with a Hologic QDR 4500 A and 
C device (Hologic Inc., Waltham, MA). The lumbar spine 
measurement was taken from dorsal projection. The regions 
of interest (ROI) at the lumbar spine were in the vertebral 
body L2 – L4. In the hip a total ROI and additional regions 
of interest were located at Ward’s triangle, femoral neck, and 
trochanter. If measurement was not possible at the lumbar 
spine or hip an additional measurement of the non-dominant 
forearm was acquired according to the guidelines of the 
ISCD [10]. Only the BMD measurement of total spine, total 
hip and femoral neck region of interest were used for 
reporting. 
 BMD was given as absolute values in g/cm
2
, and as Z 
and, T-score values. The Z-score value corresponds to the 
number of standard deviations from the mean value that was 
defined by the range of BMD of an ethnically comparable 
age and gender-matched reference population. The T-score 
value corresponds to the number of standard deviations from 
the mean of a gender-matched reference population of young 
adults defined as the Peak Bone Mass, as based on data of 
the Third National Health and Nutrition Examination Survey 
(NHANES III) provided by the manufacturer. In agreement 
with the ISCD guidelines, osteopenia or osteoporosis were 
defined according to the lowest measured value in either 
spine or hip. Osteopenia, as defined by the WHO 
classification, corresponds to a T-score value between –1.0 
and –2.5. Osteoporosis was defined a T-score value of –2.5 
and lower. Low bone mass is defined as all T-score values 
indicating osteopenia or osteoporosis [9]. 
 The two DXA devices were cross-calibrated using a 
spine phantom and daily quality controls using the same 
phantom were performed during the whole study period, 
according to the recommendations of the manufacturer. A 
maximum 1.5% variability from the mean value is 
considered as a tolerable variation of the DXA 
measurements between the two DXA devices and 0.5% 
variability for the longitudinal quality control of each 
individual device. All measurements and quality control 
were done by the same two experienced technicians during 
the whole study period. They were experienced with 6 and 9 
years at the time of this study and had measured coefficient 
of variation in short-term precision studies of 1.1% and 1.2% 
for measurements of the lumbar spine and 1.3% and 1.4% 
for measurements of the hip respectively. 
Data Analysis 
 Age and gender distribution were analyzed for all 
patients undergoing DXA during the defined period and all 
participants of the promotion action. To allow for further 
comparison of the BMD distribution the patients sent by 
their family practitioners were split into 4 groups according 
to the indication for DXA scanning and the age distribution 
of patients was adjusted to the promotion group. Only the 
females were further analysed. The following 4 groups of 
indications were created: (i) patients undergoing DXA for a 
follow-up examination, who already had at least one 
previous DXA scan in our institution. The patients of group 
(i) are very likely to have osteopenia or osteoporosis and, 
therefore, undergo control examinations for treatment 
monitoring. In group (ii) were patients under documented 
long term steroid medication for various clinical problems 
such as rheumatic diseases or patients after organ 
transplantation. The patients in group (ii) have an 
exclusively high risk to develop osteopenia and osteoporosis. 
In group (iii) were patients with documented previous 
fracture who underwent DXA for the suspicion of 
osteoporosis related fracture as a first examination before 
initiation of treatment. The patients in group (iii) are also 
likely to have a low bone mass, because of the clinical 
suspicion of an osteoporosis related fracture. In group (iv) all 
other patients were included sent by their physician with a 
range of clinical problems such as rheumatologic disease 
(patients without steroids), endocrine disorders, and 
suspected malnutrition such as anorexia. 
 Only patients with adequate quality of DXA 
measurement were used for the evaluation. For example in 
patients with bilateral hip prosthesis and degenerative 
disease at the lumbar spine or osteosynthesis and metal 
artefacts of the lumbar spine, DXA data was considered not 
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to be adequate for this study. For this analysis only results of 
BMD measurement of the lumbar spine and hip were used. 
Patients with a diagnosis of normal bone mass, osteopenia, 
or osteoporosis based on forearm measurements were not 
included. 
Statistics 
 The frequencies of osteoporosis and low bone mass at the 
lumbar spine, femoral neck, and total hip were assessed. The 
mean value and standard deviation is given for normally 
distributed values. The ranges of T-score values are tabled 
since the values can be either negative or positive. 
Confidence intervals are given at the 95% level. Mann-
Whitney U test and Fishers’ exact test were used for 
comparison. A p-value of less than 0.05 was considered to be 
significant and Bonferroni correction was done for multiple 
measurements when appropriate. 
RESULTS 
Patients and Self-Referring Persons 
 Six-hundred eighty-eight patients were sent by their 
family practitioner to undergo DXA scanning between 
September and December 2003. The data of 29 patients were 
excluded from this analysis because of insufficient 
information. Finally, 659 patients (575 females and 84 
males, mean age 58.6 ± 15.3 years, 14 – 91 years) were split 
into group (i) n=113, group (ii) n=105, group (iii) n=114, 
and group (iv) n=327. For comparison with the self-referring 
women, only the female patients of group (iv) aged 40 years 
and older were further analyzed (262 of the 327 patients of 
group (iv)). The age distribution of these female patients is 
shown in Fig. (1). 
 
Fig. (1). Age distribution of female patients of group (iv). The 
female patients of group (iv) who were sent by a family practitioner 
show a bimodal age distribution, since also young patients with 
various diseases, such as anorexia, malabsorption or rheumatic 
diseases have been sent for DXA. For further comparison the 
female patients of group (iv) being 40 years and older were used 
(n=262; mean age 59.7 ± 9.4 years). The 104 females recruited by 
the health promotion action were also 40 years and older (Fig. 2). 
 During the same period 111 persons were recruited by 
the health promotion action to undergo DXA measurement 
(mean age 63.3 ± 8.7 years, 40 – 84 years; 104 females and 7 
males). All examinations were technically suitable for 
diagnosis and further evaluation. For further evaluation, only 
data of the 104 female self-referring persons were used. The 
age distribution of the self-referring women is shown in Fig. 
(2). 
 
Fig. (2). Age distribution of self-referring women. The 104 self-
referring women had a mean age of 63.1 ± 8.6 years. 
Comparisons 
 We intended to exclude all patients with clear indications 
for DXA scanning such as given in the groups (i) to (iii) 
since they were likely to be treated by a family physician and 
DXA scanning would have probably been paid by insurance 
companies. Additionally, we excluded the male patients of 
group (iv) in the final analysis. The female patients of group 
(iv) were used in order to adapt the patient group send by 
practitioners to a comparable group of female self-referring 
persons. The female patients of group (iv), who were 
referred for scanning by their family practitioner, were used 
for comparison because they had no long-term steroid 
medication nor previous fracture and did not undergo follow-
up examination for known bone disease. Hence, the age 
distribution of patients was adjusted to the self-referring 
persons and only female patients of 40 years and older were 
used for further statistical comparison (n=262). There was 
still a significant difference in average age. The self-referring 
females had a mean age of 63.1 ± 8.6 years while the female 
patient group was 59.7 ± 9.4 years (p=0.0001, 95% CI of the 
difference 21 – 61 years). 
 In Table 1 the range, mean and median values and 
standard deviation of the total T-values of the lumbar spine 
and the T-values of the femoral neck and total hip are listed. 
There was no significant difference between the mean T-
values of the lumbar spine (p=0.09), total hip (p=0.06), and 
femoral neck (p=0.033) (significance level after Bonferroni 
correction was 0.015). The additional evaluation of 
frequencies of osteoporosis and low bone mass at the lumbar 
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spine, femoral neck, and total hip did not reveal a significant 
difference between the two groups (significance level after 
Bonferroni correction p=0.0083; Table 2). 
 Additionally, the same comparison was repeated for 
women aged 65 to 84 years (self referring females, n=46; 
female patients n=69) were included. Again, there were no 
significant differences in the frequency of low bone mass 
and osteoporosis as measured at the lumbar spine (p-values 
0.67 and 0.29), femoral neck (p-values 0.75 and 0.50), and 
total hip (p-values 0.75 and 0.34). 
DISCUSSION 
 In this study no significant differences were observed 
between the prevalence of low bone mass and osteoporosis 
between a population of self-referring females participating 
in a health promotion action and female patients who were 
sent for various indications for BMD measurement with 
DXA by a family practitioner. This might indicate that a 
health promotion action as performed with an advertisement 
in a weekly periodical can address females with a similar 
risk profile for osteoporosis as females who are sent for 
DXA with a clinical indication. In this study the self-
referring persons were approximately 4 years older than the 
patients sent by their family practitioner, which was a 
significant difference. This might indicate that the 
practitioner can react earlier on a patient’s risk profile and 
send the patient to DXA measurement. Thus, for screening 
purposes, the family practitioner could also have an 
important impact on the selection of patients. 
 There are several limitations of this retrospective 
analysis. The main limitation is certainly the small sample 
size and the recruitment in only one geographical area 
(Zurich, Switzerland) which limits the extension of the 
results. The reported number is too small to draw meaningful 
conclusions in the context of screening or health promotion 
actions. Therefore, such awareness campaigns should be 
conducted in a controlled setting and should be embedded in 
a scientific framework. In this health promotion action 
approximately 250,000 prints of the publication were 
published yet only 111 subjects self-referred in our DXA 
centre (one of 19 centres) corresponding to only 0.04 % of 
the potential population. If in all participating 19 centres as 
many self-referring women would have been examined, still 
less than 1% of the coupons would have been used. This 
might show that the self-referral campaign was not very 
successful since the self-referring subjects were only a tiny 
fraction of the publication circulation. A further limitation is 
that high risk patients were excluded. If for example a 
potential self-referring subject is on glucocorticoids perhaps 
they would not self-refer because of lack of knowledge about 
fracture risk while the family practitioners would select such 
a patient for DXA because of their medical knowledge. 
Therefore, exclusion of higher risk patients might prevent 
seeing the difference between groups and the value of having 
a family practitioner. 
 In the advertisement published in this Swiss weekly 
periodical no details about risk factors were given. However, 
a health promotion action will produce the highest impact on 
a population when optimized to the level of knowledge about 
the health problem and informing adequately to allow a 
person to make up one’s mind [4, 5]. Granted that the 
practitioners have sent patients at risk for osteoporosis for 
DXA measurement, we found that the self-referring females 
Table 1 T-Score Values at the Lumbar Spine, Femoral Neck and Total Hip 
 
 Lumbar Spine Femoral Neck Total Hip 
Self-referring females; range -3.900 - 3.200 -3.500 - 1.700 -3.000 - 2.200 
Self-referring females; mean ± SD -1.131 ± 1.469 -1.120 ± 1.072 -0.626 ± 1.093 
Self-referring females; median value -1.300 -1.300 -0.800 
Females of group (iv); range -6.400 - 3.500 -4.100 - 2.100 -3.400 - 2.200 
Females of group (iv); mean ± SD 1.288 ± 1.408 -1.220 ± 1.054 -0.729 ± 1.040 
Females of group (iv); median value -1.300 -1.300 -0.800 
The range and mean values with standard deviation (SD) of the total T-values of lumbar vertebra L2-4 and the T-values of the femoral neck and the total hip are given for the group 
of self-referring females and the group of women 40 years and older who had no long-term steroid medication nor previous fracture and who did not undergo follow-up examination 
for known bone disease. Additionally, the median value is listed showing that the two groups of self-referring females and female patients had similar bone density values. 
 
Table 2 Frequencies of Low Bone Mass and Osteoporosis 
 
Lumbar Spine Femoral Neck Total Hip 
 
Low Bone Mass Osteoporosis Low Bone Mass Osteoporosis Low Bone Mass Osteoporosis 
Self-referring females (n=104) 62 (59.6%) 19 (18.3%) 67 (64.4%) 7 (6.7%) 39 (37.5%) 6 (5.8%) 
Females of group (iv) (n=262) 161 (61.5%) 45 (17.2%) 162 (61.8%) 30 (11.5%) 113 (43.1%) 12 (4.6%) 
Fisher’s Exact p-value p=0.81 p=0.88 p=0.72 p=0.25 p=0.35 p=0.60 
The frequencies of osteoporosis and low bone mass, i.e. osteopenia and osteoporosis, at the lumbar spine (T-score value of the lumbar vertebra L2-4), the hip (total hip ROI) and the 
femoral neck are listed for all females age 40 years and older. Percentage values are given in brackets. Low bone mass is defined as a T-score value indicating osteopenia or 
osteoporosis, i.e. a value between –1.0 and lower as measured at the lumbar spine and hip. Osteoporosis is defined as a T-score value of –2.5 and lower. After Bonferroni correction 
for multiple comparisons the significance level is p=0.0083. 
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seen in our setting correctly decided themselves to undergo 
this screening test. 
 Furthermore, we interpreted the difference in age 
distribution in such a way that family practitioners are able 
to choose the riskier patients for DXA. However, there was 
no difference in bone density between the groups, a fact that 
could also indicate that family practitioners in fact are unable 
to discriminate high risk patients. Another possibility is that 
the younger population may not read the publication 
containing the coupons, or a disproportionately small 
younger population reads the publication relative to the older 
age group. The latter introduces a selection bias in the 
strategy of self-recruitment through the coupons. 
 It remains unclear whether our results are relevant to 
other settings or patient populations even regarding the same 
health promotion action and our evaluation sheds light on the 
difficulties interpreting self referral bias and performing a 
valuable health promotion action. Since DXA is not an 
optimal tool for population screening because of its limited 
availability and relatively high costs, patient selection for 
BMD testing is essential to increase the pre-test probability 
of the disease [11]. 
 We suggest that future health promotion actions on BMD 
testing in Switzerland should be scientifically accompanied 
to evaluate the public knowledge of the disease, the 
characteristics of the population screened and the effect on 
further management of patients identified by the screening 
program. Additionally, health promotion actions may cause 
uncertainty in selected populations and, thus, should be 
conducted in a controlled way [12]. It is unlikely that health 
promotion actions that are performed every once in a while 
will have a lasting and measurable effect on morbidity and 
mortality by a disease. To date, it is not clear if a screening 
program for early detection of osteoporosis and low bone 
mass would have an impact on morbidity and mortality in 
Switzerland and how such a screening program would have 
to be designed to be cost-efficient and beneficial for the 
Swiss population. 
CONCLUSION 
 The results of this retrospective study suggest that effects 
of health promotion actions are influenced by many factors. 
We found no significant difference in the prevalence of low 
bone mass or osteoporosis between self-referring women and 
female patients, suggesting that health promotion actions 
might be able to recruit the correct candidates for BMD 
testing with DXA. However, we also found that this health 
promotion action resulted in the recruitment of women being 
approximately 4 years older than female patients who were 
sent by their family practitioner. This might indicate an 
important role for the family physician who did react earlier 
on the basis of the individual patient’s risk profile. 
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